The company has been a beach of Wall Street, the priority has been to satisfy sell side analysts, that is all.
Nobody in their right mind would agree that hiring FDEs for just a few years when the learning curve is even longer- was or is a good business decision
Not sure what is driving Lilly's share price, but I decided to sell some shares at $115.07 to lock in a gain while the share price is high. I'm surprised that the company has not announced a 2 for 1 stock split.
DRs 15% dividend increase won't matter. What will matter is the fact that savings accounts and CDs will provide a better rate of return than not just this stock, but most stocks.
What we have seen so far is a "teddy bear" market. The grizzly awaits a few months down the road.